Leonard Sank, Director at ORAMED PHARMACEUTICALS INC. (ORMP.OB), bought 937,500 shares at $0.32 ($300K) on 2011-10-04, disclosed to the SEC on 2011-10-06.
Open-market purchase of $300k ORMP.OB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ORMP | BUY | 2019-07-15 | $4K | — | Filing → |
| ORMP | BUY | 2008-01-17 | $5K | — | Filing → |
| ORMP | BUY | 2008-01-09 | $7K | — | Filing → |